Precancerous Cervical Lesions Among HIV-Infected Women Attending HIV Care and Treatment Clinics in Southwest Ethiopia: A Cross-Sectional Study
Authors Lemu LG, Woldu BF, Eshetu Teke N, Bogale ND, Wondimenew EA
Received 1 December 2020
Accepted for publication 4 February 2021
Published 3 March 2021 Volume 2021:13 Pages 297—303
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Professor Elie Al-Chaer
Lidiya Gutema Lemu,1 Biruktawit Fekade Woldu,2 Natnael Eshetu Teke,3 Nardos Delelegn Bogale,1 Ermias Ayalew Wondimenew4
1Department of Midwifery, College of Health Science, Mizan Tepi University, Mizan-Aman, Ethiopia; 2Department of Midwifery, College of Medicine and Health Science, Wachemo University, Hossana, Ethiopia; 3Department of Midwifery, College of Medicine and Health Science, Wolkite University, Wolkite, Ethiopia; 4Department of Nursing, College of Health Science, Mizan Tepi University, Mizan-Aman, Ethiopia
Correspondence: Lidiya Gutema Lemu
Mizan Tepi University, Mizan-Aman, Ethiopia
Email [email protected]
Background: Despite being one of the few cancers that can be prevented with simple testing, cervical cancer is the fourth most common cancer in women. HIV-positive women showed a median three-fold higher incidence of cervical lesions.
Aim: This study aims to assess the prevalence and factors associated with precancerous cervical lesions among HIV-infected women attending care and treatment clinic in selected hospitals of Southwestern Ethiopia.
Methods: Institution-based cross-sectional study was conducted from February 1 to July 30, 2018. A systematic random sampling technique was employed to select 454 HIV-infected women. Pretested interviewer-administered questionnaire and medical record review were used for data collection. Visual inspection with Acetic acid was done for participants to detect precancerous cervical lesions. Data were analyzed by SPSS version 20. Binary and multiple logistic regression analyses were done. The presence and strength of association were determined using AOR with its 95% CI. Variables with a P value of less than 0.05 were considered as statistically significant.
Results: The prevalence of precancerous cervical lesion was 18.7% [95% CI; (15.1– 22.4%)]. Currently, not being on highly active antiretroviral treatment [AOR= 2.31, 95% CI: 1.23– 4.39], age (20– 29 years) [AOR= 0.185, 95% CI: 0.036,0.939], has no history of sexually transmitted infection [AOR=0.026, 95% CI: 0.006– 0.116], has no history of genital wart [AOR= 0.261, 95% CI: 0.073– 0.934] and having one lifetime sexual partner [AOR=0.133, 95% CI: 0.024– 0.726] were found to be significantly associated with precancerous cervical lesion.
Conclusion: The prevalence of Precancerous Cervical lesion was found to be high in this study. Expansion of screening services and undertaking preventive measures against sexually transmitted infection need to be emphasized.
Keywords: precancerous cervical lesion, HIV positive, prevalence, factors, Ethiopia
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]